BioCatalystWatch
BCAXWorkspace / BCAX / OverviewCompany library
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc.

Bicara Therapeutics Inc. (BCAX)

Website

Price
Market cap
Next catalystJan 2027ficerafusp alfa — mCRC monotherapy and pembrolizumab-combination expansion cohorts · Phase 1 dataCompany release ↗
Cash

Chart & Events

Candle interval

Core Clinical

ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved
Upcoming / outlook

ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved
Upcoming / outlook

ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Other pipelines

ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved
Upcoming / outlook

BCA356

CAIX

PreINDP1P2P3FilingApproved

History / paused

ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved
ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved
ficerafusp alfa

EGFR × TGF-β

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BCAX PR & News

PR & News

BCAX SEC archive